UIS SHAREHOLDER ALERT: Jakubowitz Law Reminds Unisys Shareholders of a Lead Plaintiff Deadline of January 10, 2023

G Medical Innovations Holdings Ltd

Change company Symbol lookup

Select an option...

GMVD G Medical Innovations Holdings Ltd

CMPX Compass Therapeutics Inc.

AMST Amesite Inc

AMPX Amprius Technologies Inc

PRTK Paratek Pharmaceuticals Inc

EGRAY Energy Resources Of Australia Ltd

IVAC Intevac Inc

PFE Pfizer Inc

BNOX Bionomics Ltd

CRKN Crown Electrokinetics Corp.

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Providers & Services | Small Cap Value
Based in Cayman Islands

Company profile

G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.

UIS SHAREHOLDER ALERT: Jakubowitz Law Reminds Unisys Shareholders of a Lead Plaintiff Deadline of January 10, 2023

5:45 am ET January 6, 2023 (PR Newswire) Print

Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Unisys Corporation (NYSE: UIS).

To receive updates on the lawsuit, fill out the form:https://claimyourloss.com/securities/unisys-corporation-loss-submission-form/?id=35347&from=4

The lawsuit seeks to recover losses for shareholders who purchased Unisys between August 3, 2022 andNovember 7, 2022.

Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until January 10, 2023 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

According to a filed complaint, Unisys Corporation issued materially false and/or misleading statements and/or failed to disclose that: (i) the Company's 2022 financial guidance was significantly overstated; (ii) accordingly, once the truth was revealed, it was likely that the Company would be required to negatively revise its 2022 financial guidance; (iii) in addition to the foregoing, material weaknesses existed in the Company's internal control over financial reporting; and (iv) as a result of all of the foregoing, the Company's public statements were materially false and misleading at all relevant times.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:JAKUBOWITZ LAW1140 Avenue of the Americas9th FloorNew York, New York 10036T: (212) 867-4490F: (212) 537-5887

https://c212.net/c/img/favicon.png?sn=NY79419&sd=2023-01-06

View original content:https://www.prnewswire.com/news-releases/uis-shareholder-alert-jakubowitz-law-reminds-unisys-shareholders-of-a-lead-plaintiff-deadline-of-january-10-2023-301715087.html

SOURCE Jakubowitz Law

https://rt.newswire.ca/rt.gif?NewsItemId=NY79419&Transmission_Id=202301060545PR_NEWS_USPR_____NY79419&DateId=20230106

COMTEX_422224387/1005/2023-01-06T05:45:07